Contrast-enhanced ultrasound to tell apart GIST and leiomyoma tumors
Part of Cancer, Digestive system clinical trials.
This trial uses a special ultrasound technique to look at growths in the digestive tract and help tell the difference between two types of tumors, GISTs and leiomyomas. It may help improve diagnosis and guide treatment for people with these growths.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 85 years old.
- You already have a confirmed diagnosis of either a GIST (a type of tumor in the digestive tract) or a leiomyoma (a usually non-cancerous tumor in the muscle layer).
- Your hemoglobin level (a blood protein that carries oxygen) must be higher than 8.0 g/dL.
- You must not be allergic to ultrasound contrast agents (the dye used for imaging).
- You must not be pregnant.
- You must not have severe heart or lung problems that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to help diagnose tumors in the upper stomach or esophagus. It looks at images from endoscopy and ultrasound to improve how doctors identify these growths.
This trial tests a new surgical approach combining laparoscopic (minimally invasive) surgery with endoscopy (a camera procedure) to remove small tumors located where the esophagus meets the stomach. The goal is to safely remove these tumors while preserving normal function.
This study looks at how surgery for gastrointestinal stromal tumors (GIST) works, and collects tumor samples to study them under the microscope and by DNA testing. Your results may help researchers better predict tumor behavior and guide future treatment.
This study looks at why some GIST tumors stop responding to standard treatments. It uses special imaging and genetic testing of tumor tissue to find resistance patterns, which may guide future treatment choices.
This trial compares two special camera methods (pCLE and EB) used during endoscopy to better see and diagnose early stomach changes. It may help doctors decide the best treatment for precancerous spots or very early cancer.
This trial compares two endoscopic techniques (EFTR and STER) for removing small to medium-sized GIST tumors from the stomach wall. It aims to see which method is safer and more effective.
Hear when a new Gastrointestinal Stromal Tumor (GIST) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.